Howland Capital Management’s Tempest Therapeutics TPST Stock Holding History

Howland Capital Management’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21	Closed	-$46K	–	210
2018 Q3	$46K	Hold	21	–	–	﹤0.01%	219
2018 Q2	$57K	Hold	21	–	–	﹤0.01%	211
2018 Q1	$51K	Hold	21	–	–	﹤0.01%	213
2017 Q4	$88K	Hold	21	–	–	0.01%	219
2017 Q3	$89K	Sell	21 -19	-48%	-$81.2K	0.01%	219
2017 Q2	$183K	Hold	40	–	–	0.02%	217
2017 Q1	$220K	Hold	40	–	–	0.02%	207
2016 Q4	$180K	Hold	40	–	–	0.02%	204
2016 Q3	$842K	Hold	40	–	–	0.08%	119
2016 Q2	$612K	Sell	40 -5	-11%	-$114K	0.06%	138
2016 Q1	$1.26M	Sell	45 -11	-20%	-$233K	0.13%	100
2015 Q4	$1.59M	Hold	56	–	–	0.16%	91
2015 Q3	$1.38M	Sell	56 -3	-5%	-$202K	0.15%	94
2015 Q2	$4.96M	Hold	59	–	–	0.51%	62
2015 Q1	$5.95M	Buy	59 +44	+293%	+$5.86M	0.61%	58
2014 Q4	$1.97M	Sell	15 -4	-21%	-$293K	0.2%	85
2014 Q3	$907K	Buy	+19	New	+$666K	0.09%	110

Other funds holding TPST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TFCP

Twin Focus Capital Partners Boston, Massachusetts $871M AUM 27.72% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Howland Capital Management's TPST Position: Q4 2018 in Review

Howland Capital Management sold out of Tempest Therapeutics (TPST) in Q4 2018, closing a stake of 21 shares — an estimated $46K sold.

Howland Capital Management first reported a position in TPST in Q3 2014 and held it in 17 quarters. The position peaked at $5.95M in Q1 2015. 30 funds tracked by Wall St. Rank hold TPST as of Q4 2018.

Howland Capital Management reported no remaining Tempest Therapeutics position as of Q4 2018 after selling out during the quarter.
Howland Capital Management sold 21 Tempest Therapeutics shares in Q4 2018, an estimated $46K.
Howland Capital Management first reported a position in Tempest Therapeutics in Q3 2014 and held it in 17 quarters.
Howland Capital Management's Tempest Therapeutics position peaked at $5.95M in Q1 2015.
30 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2018.

Based on Howland Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.